16641860

Diamanti-Kandarakis E

2006

Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS.

16641861

Marouliss GB

2006

Polycystic ovarian disease: the adrenal connection.

16641862

Zapanti E

2006

Treatment options of polycystic ovary syndrome in adolescence.

16647374

Pasquali R

2006

Obesity and androgens: facts and perspectives.

16647382

Palomba S

2006

Metformin hydrochloride and recurrent miscarriage in a woman with polycystic ovary syndrome.

16647666

Miller EL

2006

Metabolic syndrome: screening, diagnosis, and management.

16647909

Banaszewska B

2006

Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin.

16648288

Froment P

2006

Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.

16648776

Marianowski P

2006

The changes of hormonal serum levels and ovulation/pregnancy rates after ovarian electrocautery in microlaparoscopy and laparoscopy in patients with PCOS.

16650415

Pinhas-Hamiel O

2006

Clinical and laboratory characteristics of adolescents with both polycystic ovary disease and anorexia nervosa.

16650417

Pall M

2006

Family size in women with polycystic ovary syndrome.

16650418

Panidis D

2006

Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.

16670102

Blank SK

2006

The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.

16675483

Escobar-Morreale HF

2006

Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.

16677059

Elkind-Hirsch KE

2006

Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.

16677694

Villavicencio A

2006

Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.

16682845

Essah PA

2006

The metabolic syndrome in polycystic ovary syndrome.

16684824

Poretsky L

2006

Commentary: Polycystic ovary syndrome--increased or preserved ovarian sensitivity to insulin?

16684838

Chen X

2006

Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.

16685527

Matalliotakis I

2006

Polycystic ovary syndrome: etiology and pathogenesis.

16687201

Casadei L

2006

Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.

16688018

Biton V

2006

Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agent.

16689284

Aisaka K

2006

[Gn-RH loading test].

16689285

Hayashi N

2006

[Pulsatile GnRH therapy for hypogonadotropic hypogonadism and other ovulatory disorders].

16689328

Fujiwara T

2006

[Polycystic ovary syndrome].

16689353

Sueoka K

2006

[Androgen and reproductive physiology].

16691383

Hassa H

2006

Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.

16698631

Turner MJ

2006

Outcome of clinical pregnancies after ovulation induction using metformin.

16699296

Burelli A

2006

Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome.

16700688

Snyder BS

2006

The lived experience of women diagnosed with polycystic ovary syndrome.

16704758

Cho LW

2006

The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.

16704856

Wikiera B

2006

[Pituitary response to GnRH analogue testing in girls with a polycystic ovary syndrome].

16705549

Hahn S

2006

The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.

16705550

Mueller A

2006

Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.

16707769

Santos FC

2006

Testosterone stimulates growth and secretory activity of the female prostate in the adult gerbil (Meriones unguiculatus).

16709603

Lam PM

2006

The role of three-dimensional ultrasonography in polycystic ovary syndrome.

16710750

Martins Wde P

2006

Endometrial preparation for in vitro oocyte maturation: early use of estrogen increases endometrial tissue and requires lower daily dosage: a cross over trial in 'mock' cycles.

16712660

La Marca A

2006

Anti-M?llerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?

16715935

Seki A

2006

[Polycystic ovary syndrome and hepatocellular adenoma related to long-term use of sodium valproate in a young woman].

16716164

Ska?ba P

2006

Content of 5-alpha-reductase (type 1 and type 2) mRNA in dermal papillae from the lower abdominal region in women with hirsutism.

16716324

Essah PA

2006

Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome.

16720653

Wachs DS

2006

Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women.

16720659

Sir-Petermann T

2006

Increased anti-M?llerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.

16723690

Sule AA

2006

Association of polycystic ovary syndrome and fibromyalgia in a patient with primary hyperparathyroidism: a novel triad?

16725287

Pasquali R

2006

Obesity, fat distribution and infertility.

16728382

Diamanti-Kandarakis E

2006

Polycystic ovary syndrome: the influence of environmental and genetic factors.

16728533

Pasquali R

2006

Insulin-sensitizing agents in polycystic ovary syndrome.

16728549

Dagre A

2006

Association of dehydroepiandrosterone-sulfate with endothelial function in young women with polycystic ovary syndrome.

16730719

Lydic ML

2006

Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome.

16731088

Branigan EF

2006

Thorough sonographic oocyte retrieval during in vitro fertilization produces results similar to ovarian wedge resection in patients with clomiphene citrate-resistant polycystic ovarian syndrome.

16731417

Vanwinter JT

2006

Do changes associated with polycystic ovary syndrome begin before menarche?

16735828

Unlu C

2006

Surgical treatment in polycystic ovary syndrome.

16735830

Cervero A

2006

The role of the leptin in reproduction.

16736136

Tamai K

2006

MR features of physiologic and benign conditions of the ovary.

16737024

Urman B

2006

Ovulatory disorders and infertility.

16737862

Liu JH

2006

Expanding applications for metformin in polycystic ovarian syndrome.

16737874

Glueck CJ

2006

Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome.

16740005

Stankiewicz M

2006

Diagnosis and management of polycystic ovary syndrome: a practical guide.

16750203

Cagnacci A

2006

Oral contraceptives and insulin sensitivity.

16750596

Witchel SF

2006

Puberty and polycystic ovary syndrome.

16750830

Bloom MS

2006

Selecting controls is not selecting normals: design and analysis issues for studying the etiology of polycystic ovary syndrome.

16752800

Duskov? M

2006

The existence of a male equivalent of the polycystic ovary syndrome--the present state of the issue.

16753044

Lord J

2006

The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.

16757104

Heger S

2006

Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.

16757529

Orio F Jr

2006

Cardiopulmonary impairment in young women with polycystic ovary syndrome.

16757555

Chen MJ

2006

Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.

16758344

Hauzman EE

2006

Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.

16759463

Yang XF

2006

[Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].

16759919

Carmina E

2006

The spectrum of androgen excess disorders.

16760380

Tosca L

2006

Metformin-induced stimulation of adenosine 5' monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells.

16760656

Jamnongjit M

2006

Ovarian steroids: the good, the bad, and the signals that raise them.

16762348

Douglas CC

2006

Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.

16762349

Kelestimur F

2006

Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.

16764037

Lu XE

2006

[Outcome of in vitro fertilization-embryo transfer in treatment of polycystic ovarian syndrome].

16764619

Kocak I

2006

Effects of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling.

16764871

Wang Y

2006

A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome.

16766228

Hart R

2006

Polycystic ovarian syndrome--prognosis and outcomes.

16767294

Silva Rdo C

2006

[Polycystic ovary syndrome, metabolic syndrome, cardiovascular risk and the role of insulin sensitizing agents].

16767302

Carvalheira JB

2006

[Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].

16769057

Vlaisavljevi? V

2006

Multinucleation and cleavage of embryos derived from in vitro-matured oocytes.

16769059

Wang JG

2006

Initial presentation of undiagnosed acute intermittent porphyria as a rare complication of ovulation induction.

16769061

Fulghesu AM

2006

Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.

16769248

Diamanti-Kandarakis E

2006

Molecular mechanisms of insulin resistance in polycystic ovary syndrome.

16769740

Himelein MJ

2006

Depression and body image among women with polycystic ovary syndrome.

16769748

Moll E

2006

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial.

16772149

Yildiz BO

2006

Diagnosis of hyperandrogenism: clinical criteria.

16772151

Goodarzi MO

2006

Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.

16772152

Carmina E

2006

Mild androgen phenotypes.

16772153

Moghetti P

2006

Treatment of hirsutism and acne in hyperandrogenism.

16772154

Giudice LC

2006

Endometrium in PCOS: Implantation and predisposition to endocrine CA.

16772155

Sharma ST

2006

Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.

16772156

van Santbrink EJ

2006

Ovulation induction in normogonadotropic anovulation (PCOS).

16772157

Balen A

2006

Surgical treatment of polycystic ovary syndrome.

16772158

Homburg R

2006

Pregnancy complications in PCOS.

16772159

Hoeger KM

2006

Role of lifestyle modification in the management of polycystic ovary syndrome.

16772160

Warren-Ulanch J

2006

Treatment of PCOS in adolescence.

16772161

Legro RS

2006

A twenty-first century research agenda for polycystic ovary syndrome.

16779985

Kurabayashi T

2006

Association of polymorphisms in the beta2 and beta3 adrenoceptor gene with polycystic ovary syndrome.

16781743

Doi SA

2006

Steroidogenic alterations and adrenal androgen excess in PCOS.

16782094

Glintborg D

2006

Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.